Gingko biloba extract (EGb 761) attenuates the focal cerebral ischemic injury-induced decrease in astrocytic...

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• Focal cerebral ischemic injury can lead to neuronal damage.
• Phosphoprotein enriched in astrocytes 15 (PEA-15) plays a role in regulating cell apoptosis.
• EGb 761, a Ginkgo biloba extract, exhibits neuroprotective properties.

Purpose of the Study:

• To investigate the effect of EGb 761 on PEA-15 expression and phosphorylation in a rat model of cerebral ischemic injury.
• To determine if EGb 761 can prevent the reduction of PEA-15 and its phosphorylated forms following middle cerebral artery occlusion (MCAO).

Main Methods:

• Adult male rats underwent MCAO to induce ischemic injury.
• Rats were pretreated with either vehicle or EGb 761 (100 mg/kg).
• Proteomic and Western blot analyses were used to assess PEA-15 and phospho-PEA-15 (Ser 104, Ser 116) levels in cerebral cortices 24 hours post-MCAO.

Main Results:

• MCAO injury significantly reduced the expression of PEA-15 and its phosphorylated forms.
• EGb 761 pretreatment effectively prevented the MCAO-induced decrease in PEA-15 expression.
• EGb 761 attenuated the reduction in phospho-PEA-15 (Ser 104) and phospho-PEA-15 (Ser 116) caused by ischemic injury.

Conclusions:

• EGb 761 maintains PEA-15 expression and phosphorylation during cerebral ischemic injury.
• The neuroprotective effect of EGb 761 against cerebral ischemia may be mediated through the regulation of PEA-15 phosphorylation.
• Preserving PEA-15 phosphorylation is crucial for its anti-apoptotic function and neuroprotection.